| Literature DB >> 23539000 |
Aretha Brito Nobre1, Juan Piñeiro-Maceira, Ronir Raggio Luiz.
Abstract
BACKGROUND: Dysplastic nevi are among the most important cutaneous melanoma simulators. They are important risk markers for this neoplasia and can be its potential precursors. Some authors found a statistically significant relationship between the degree of dysplasia and the risk for developing melanoma. However, reproducibility of grading criteria ranged from poor to fair in the researched articles.Entities:
Mesh:
Year: 2013 PMID: 23539000 PMCID: PMC3699937 DOI: 10.1590/s0365-05962013000100002
Source DB: PubMed Journal: An Bras Dermatol ISSN: 0365-0596 Impact factor: 1.896
Form distributed to panel members for grading lesions
| 1. Downgrowth and complexity of the epidermal ridge pattern, with hyperplasia of melanocytes in a disordered growth. |
| 2. Host response of perivascular lymphocytes and lamellar fibroplasia. |
| 3. Cytologic atypia not prominent in mild and moderate categories; cytologic atypia and entrapment of dysplastic nevus cells in desmoplastic subepidermal collagen present in severe dysplasia. |
| Note: If there is disagreement in the diagnosis of dysplastic melanocytic nevi, the new diagnosis must be placed in the "OBS" field of the grading form and, therefore, the lesion should not be graded. |
Source: Sagebiel RWet al, 1985.[11]
Diagnostic comparison between the dermatopathologist and general pathologist during preliminary assessment
| Total | 4 | 30 | 32 | 10 | 2 | 1 | 1 | 2 | 2 | 2 | 89 | |
| CN | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | |
| MiD | 2 | 14 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 18 | |
| MoD | 2 | 9 | 32 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 46 | |
| SD | 0 | 5 | 2 | 6 | 0 | 0 | 0 | 0 | 0 | 1 | 14 | |
| MIS | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 3 | |
| AJN/MIS | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | |
| RN | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | |
| Prolifat mel | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | |
CN: “conventional” (non-dysplastic) melanocytic nevus; MiD: dysplastic melanocytic nevus with mild dysplasia; MoD: dysplastic melanocytic nevus with moderate dysplasia; SD: dysplastic melanocytic nevus with severe dysplasia; MIS: melanoma in situ; AJN/MIS: atypical (dysplastic) junctional nevus/ melanoma in situ; RN: Reed nevus; Prolif at mel: proliferation of atypical melanocytes ; IM: invasive melanoma.
Frequency of diagnoses made by the different observers in the 75 cases of dysplastic nevi previously selected.
| Total | 75 (100,0) | 75 (100,0) | 75 (100,0) | 75 (100,0) | 75 (100,0) | 75 (100,0) | 75 (100,0) | 75 (100,0) | 75 (100,0) | 75 (100,0) |
| CN | 14 (18.7) | - | 7 (9.3) | 16 (21.3) | 23 (30.7) | - | 4 (5.3) | 20 (26.7) | - | 3 (4.0) |
| Mi | 27 (36.0) | 24 (32.0) | 28 (37.3) | 27 (36.0) | 28 (37.3) | 44 (58.7) | 25 (33.3) | 30 (40.0) | 30 (40.0) | 16 (21.3) |
| MoD | 23 (30.7) | 35 (46.7) | 26 (34.7) | 15 (20.0) | 15 (20.0) | 26 (34.7) | 32 (42.7) | 19 (25.3) | 35 (46.7) | 42 (56.0) |
| SD | 10 (13.3) | 16 (21.3) | 6 (8.0) | 14 (18.7) | 9 (12.0) | 5 (6.7) | 14 (18.7) | 4 (5.3) | 10 (13.3) | 13 (17.3) |
| MIS | 1 (1.3) | - | 1 (1.3) | - | - | - | - | - | - | 1 (1.3) |
| IM | - | - | 7 (9.3) | - | - | - | - | - | - | - |
Interobserver agreement - Weighted kappa values, p-value, standard-error and percentage of agreement for each pair of observers
| A versus B | 0.01 | 0.417 | 0.07 | 24.0 |
| A versus C | 0.09 | 0.072 | 0.07 | 29.3 |
| B versus C | 0.12 | 0.033 | 0.06 | 36.0 |
| A versus I | 0.09 | 0.104 | 0.07 | 26.6 |
| B versus I | 0.26 | 0.001 | 0.09 | 58.6 |
| C versus I | 0.18 | 0.003 | 0.06 | 41.3 |
| A versus D | 0.18 | 0.010 | 0.08 | 33.3 |
| A versus E | -0.01 | 0.562 | 0.08 | 22.6 |
| A versus F | 0.16 | 0.014 | 0.07 | 42.6 |
| A versus J | 0.10 | 0.057 | 0.07 | 29.3 |
| B versus D | 0.14 | 0.018 | 0.07 | 36.1 |
| B versus E | 0.16 | 0.002 | 0.06 | 26.6 |
| B versus F | 0.13 | 0.045 | 0.08 | 44.0 |
| B versus J | 0.27 | < 0.001 | 0.08 | 54.6 |
| C versus D | 0.08 | 0.108 | 0.07 | 30.5 |
| C versus E | 0.15 | 0.006 | 0.06 | 32.0 |
| C versus F | 0.09 | 0.070 | 0.06 | 37.3 |
| C versus J | 0.05 | 0.204 | 0.06 | 32.0 |
| D versus I | 0.22 | 0.001 | 0.07 | 37.5 |
| E versus I | 0.16 | 0.003 | 0.06 | 32.0 |
| F versus I | 0.14 | 0.051 | 0.09 | 46.6 |
| D versus E | 0.34 | < 0.001 | 0.08 | 37.5 |
| D versus F | 0.12 | 0.048 | 0.07 | 40.2 |
| D versus J | 0.31 | < 0.001 | 0.07 | 40.2 |
| E versus F | -0.01 | 0.593 | 0.06 | 18.6 |
| E versus J | 0.21 | < 0.001 | 0.06 | 33.3 |
| F versus J | 0.13 | 0.031 | 0.07 | 36.0 |
| G versus H | 0.05 | 0.210 | 0.06 | 27.3 |
| A versus G | 0.04 | 0.314 | 0.07 | 28.0 |
| A versus H | 0.22 | 0.002 | 0.08 | 39.7 |
| B versus G | -0.01 | 0.542 | 0.08 | 33.3 |
| B versus H | 0.10 | 0.026 | 0.05 | 32.8 |
| C versus G | 0.11 | 0.053 | 0.07 | 29.3 |
| C versus H | 0.02 | 0.393 | 0.06 | 21.9 |
| G versus I | 0.15 | 0.034 | 0.08 | 40.0 |
| H versus I | 0.20 | < 0.001 | 0.06 | 32.8 |
| D versus G | -0.03 | 0.655 | 0.07 | 23.6 |
| D versus H | 0.35 | < 0.001 | 0.08 | 48.5 |
| E versus G | -0.09 | 0.910 | 0.06 | 20.0 |
| E versus H | 0.25 | 0.001 | 0.08 | 35.6 |
| F versus G | 0.17 | 0.015 | 0.08 | 44.0 |
| F versus H | 0.13 | 0.028 | 0.07 | 43.8 |
| G versus J | 0.12 | 0.055 | 0.08 | 42.6 |
| H versus J | 0.12 | 0.010 | 0.05 | 32.8 |
Average values of weighted kappa
| Total number of observers | 0.13 (-0.09 - 0.35) |
| Dermatopathologists | 0.12 (0.01 - 0.26) |
| Dermatopathologists x general pathologists | 0.13 (-0.01 - 0.27) |
| General Pathologists | 0.18 (-0.01 - 0.34) |
| Dermatopathologists x residents | 0.10 (-0.01 - 0.22) |
| General pathologists x residents | 0.12 (-0.09 - 0.35) |
Frequency of the average score for the diagnosis of dermatopathologists
| MiD | 1.15 to 2.25 | 20 | 26.6 |
| MoD | 2.75 to 3.25 | 27 | 36.1 |
| SD | 3.75 to 4.25 | 4 | 5.3 |
| MIS | 4.75 | 1 | 1.3 |
| no consensus | 2.50 and 3.50 | 23 | 30.7 |
MiD: dysplastic melanocytic nevus with mild dysplasia;
MoD: dysplastic melanocytic nevus with moderate dysplasia; SD: dysplastic melanocytic nevus with severe dysplasia; MIS: melanoma in situ.
Cases with greater diagnostic difficulty among dermatopathologists
| MoD | MiD | MIS | SD | |
| CN | SD | MoD | MiD | |
| CN | MiD | MoD | SD | |
CN: “conventional” (non-dysplastic) melanocytic nevus or lentigo; MiD: dysplastic melanocytic nevus with mild dysplasia;
MoD: dysplastic melanocytic nevus with moderate dysplasia;
SD: dysplastic melanocytic nevus with severe dysplasia; MIS: melanoma in situ
Frequency of the average score for the diagnosis of general pathologists.
| CN | 1.25 | 1 | 1.4 |
| MiD | 1.75 to 2.25 | 29 | 40.2 |
| MoD | 2.75 to 3.25 | 24 | 33.3 |
| SD | 3.75 to 4.25 | 4 | 5.6 |
| no consensus | 1.50. 2.50 and 3.50 | 14 | 19.5 |
CN: “conventional” (non-dysplastic) melanocytic nevus or lentigo; MiD: dysplastic melanocytic nevus with mild dysplasia; MoD: dysplastic melanocytic nevus with moderate dysplasia; SD: dys-plastic melanocytic nevus with severe dysplasia; MIS: melanoma in situ.
Cases with greater diagnostic difficulty among general pathologists.
| SD | CN | MiD | MoD | |
| AL | CN | MiD | MoD | |
CN: “conventional” (non-dysplastic) melanocytic nevus or lentigo; MiD: dysplastic melanocytic nevus with mild dysplasia; MoD: dys-plastic melanocytic nevus with moderate dysplasia; SD: dysplastic melanocytic nevus with severe dysplasia; AL: atypical lentigo.